Better Therapeutics Inc. (BTTX)
0.00
null (null%)
At close: Jan 16, 2025, 3:00 PM
0.01
7300.00%
Pre-market Jun 20, 2024, 09:30 AM EDT
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY22 | FY21 | FY20 | FY19 |
| Net Income | -39.76M | -40.34M | -6.39M | -5.78M |
| Depreciation & Amortization | 2.73M | 1.62M | 75.00K | 72.00K |
| Stock-Based Compensation | 1.82M | 646.00K | 233.00K | 84.00K |
| Other Working Capital | 4.76M | -3.35M | 125.00K | -521.00K |
| Other Non-Cash Items | 9.00K | 9.74M | -153.00K | -505 |
| Deferred Income Tax | n/a | -152.00K | 152.00K | 505.00 |
| Change in Working Capital | 6.27M | -2.34M | 306.00K | -589.00K |
| Operating Cash Flow | -28.93M | -30.82M | -5.77M | -6.22M |
| Capital Expenditures | -1.18M | -1.07M | -2.31M | -2.74M |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -1.07M | -1.02K | -2.29K | -2.69K |
| Investing Cash Flow | -1.18M | -1.07M | -2.31M | -2.74M |
| Debt Repayment | 5.00M | 28.68M | n/a | 5.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 284.00K | 43.66M | 7.45M | 3.70M |
| Financial Cash Flow | 5.28M | 72.33K | 7.45M | 8.70M |
| Net Cash Flow | -24.83M | 40.44M | -634.00K | -253.00K |
| Free Cash Flow | -30.11M | -31.89M | -8.08M | -8.95M |